NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology

Matthew J. Higgins, Paula E. Stephan, Jerry G. Thursby

NBER Working Paper No. 14602
Issued in December 2008
NBER Program(s):Labor Studies, Productivity, Innovation, and Entrepreneurship

Managers of private entrepreneurial firms face obstacles in raising capital both in placing a value on a firm and conveying value to investors. These problems are exacerbated when the firm is small, has limited assets (except for human capital) and has yet to have a lead product. In such cases metrics are necessary to convey the value of the firm to investors. Here we explore the importance within the biotechnology industry of the non-financial metrics firms used to convey value during two important initial public offerings (IPO) windows (1989 to 1992 and 1996 to 2000). We also examine whether there was a change over time in the importance of various metrics in determining the value of a biotechnology firm. We find that firms with an affiliated Nobel laureate succeeded in raising the value of their firms by more than $30 million compared to firms without a Nobel laureate during the first period, suggesting that a Nobel laureate served as a powerful signal of firm value. Our results also suggest that the biotechnology regime changed and the Nobel Prize lost its luster as a signal of value in the second period. The importance of several other non-financial metrics changed as well. We conclude that these non-financial metrics of value change in relative importance to potential investors and financial markets as learning occurs and as an industry matures.

download in pdf format
   (212 K)

email paper

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w14602

Published: Research Policy 2011 | 40 | 4 | 605-617 Conveying quality and value in emerging industries: Star scientists and the role of signals in biotechnology Matthew J. Higgins Paula E. Stephan Jerry G. Thursby

Users who downloaded this paper also downloaded* these:
Zucker and Darby w12172 Movement of Star Scientists and Engineers and High-Tech Firm Entry
Golec and Vernon w13604 Financial Risk in the Biotechnology Industry
Berndt, Bui, Lucking-Reiley, and Urban The Roles of Marketing, Product Quality, and Price Competition in the Growth and Composition of the U.S. Antiulcer Drug Industry
Jensen, Thursby, and Thursby w15732 University-Industry Spillovers, Government Funding, and Industrial Consulting
Chen, Gompers, Kovner, and Lerner w15102 Buy Local? The Geography of Successful and Unsuccessful Venture Capital Expansion
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us